Resthetics, founded in 2015, aims to convert waste anesthetic gas into a renewable resource. Originating from interdisciplinary research at the University of Houston, the company developed a porous crystalline organic framework with a high affinity for fluorinated anesthetics. This technology allows for the efficient capture and desorption of anesthetic molecules, significantly reducing harmful HFC emissions. Resthetics focuses on selling recaptured fluorinated anesthetics, targeting the healthcare and environmental sustainability markets.
Notable affiliated individuals include researchers from the University of Houston who contributed to the core technology. The company has attracted attention from investors interested in green technologies and sustainable healthcare solutions. Key achievements include the development of a patented process capable of capturing 99.5% of exhausted anesthetic gases, which has been recognized in various scientific publications. Resthetics has made a significant impact by promoting environmental sustainability and offering cost-effective solutions for healthcare facilities.

Claros Technologies
clarostech.com

Reterro

CarbonBridge
carbonbridge.io

Propellane
propellane.eu

CarbonBright
carbonbright.co

Hyperion Global Energy
hyperionenergy.ca

trace
trace.tech

RenewWest
renewwest.com

ECGO
ecgo.co

Kudoti
kudoti.com

EnMass Energy

Cancrie
cancrie.co

Carbon Limit
carbonlimit.com

EcoWastehub

EnviCore
envicoreinc.com
Organizations similar to Resthetics include Reterro, Propellane, CarbonBright and Hyperion Global Energy.
Resthetics was founded in 2015.
Resthetics' headquarters is located in Houston, TX, US.
As of Feb 21, 2018, Resthetics has raised a total of $2k (USD).
Resthetics has 1 employee as of Feb 4, 2024.